Wednesday, November 29, 2006 6:00:00 AM PDT | VentureDeal Staff
MA -- Magellan Biosciences announced the
closing of a $50 million round of new debt and equity financing.
Funds will be used to expand product development and strategic acquisitions.
The company develops products for clinical diagnostics, hospital-based labs and
near-patient testing and serves markets worldwide.
Abingworth Management led the round, which included seven previous and new
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
Learn More »
Email Sign Up
© 2014 VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.